Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors. Its structure supports binding to enzyme active sites, making it valuable in creating drugs targeting inflammatory diseases and certain cancers. The compound's trifluoromethyl group enhances metabolic stability and bioavailability, which improves drug efficacy. It is also employed in agrochemical research for designing novel pesticides with improved selectivity and environmental profiles.